The Maine Health Data Organization (MHDO) is mandated to collect pricing component data from prescription drug manufacturers, wholesale drug distributors, and pharmacy benefit managers. This data includes information on costs and payments related to making prescription drugs available to consumers.

4 views • 25 slides

The proposed rulemaking by the Maine Healthcare Data Organization (MHDO) focuses on implementing a uniform reporting system for prescription drug price data sets and collecting non-claims-based primary care provider payments. The timeline for this update includes public hearings and board reviews to

0 views • 20 slides

This content provides insights into the recent discussions and initiatives undertaken by the Maine Health Data Organization (MHDO) Board, including rulemaking timelines for non-claims based payments, an overview of an APCD Federal Grant Opportunity, updates on legislative sessions, and reports on pu

0 views • 30 slides

The MHDO Board Meeting held on September 23, 2021, discussed key topics including final adoption of Rule Chapter 570, updates on the Health Information Advisory Committee (HIAC) requirements, reports due to the Legislature, CompareMaine 10.0, and upcoming next steps. Issues related to Rule Chapter 5

0 views • 17 slides